Investing.com - Celon Pharma reported on Wednesday third quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Celon Pharma announced earnings per share of zł-0.10 on revenue of zł46M. Analysts polled by Investing.com anticipated EPS of zł-0.10 on revenue of zł45.1M.
Celon Pharma shares are down 60.84% from the beginning of the year, still down 66.76% from its 52 week high of zł39.05 set on October 19, 2021.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar